CompoAtlas

QUEEN FIT™ Define It Lady™ (Paziņots 2015.)

Food supplement registered in Latvia

Register snapshot dated 2 May 2025. It does not establish the current status of the product.

Number published by PVD
0000639/2015
Type
Food supplement
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
Vitatrade, SIA
Manufacturer
OLIMP LABORATORIES Sp. z.o.o.
Origin
Latvija
Register snapshot
2 May 2025
Recommended daily intake (Latvian text)
2 tabletes dienā
Published pack size
Tablete pa 1.09 g
Published packaging
Pa 60 tabletēm

This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

The foreign register category does not determine the regulatory category of the product in France.

Published composition

Published namePublished text and quantityRecognised ingredientRole or context
NIACĪNSvitamins ; NIACĪNS ; 21.2 ; mg NEVitamine B3 (niacine)Vitamin or mineral
Magnijsminerals ; Magnijs ; 37.5 ; mgMagnésiumVitamin or mineral
Hromsminerals ; Hroms ; 26.6 ; μgChromeVitamin or mineral
Nātru ekstraktsplants ; Nātru ekstrakts ; Urtica dioica L. ; 200 ; mgurtica dioicaPlant
Zaļās tējas ekstraktsplants ; Zaļās tējas ekstrakts ; Camellia sinensis ; 110 ; mgcamellia sinensisPlant
Aveņu augļu ekstraktsplants ; Aveņu augļu ekstrakts ; Rubus idaeus ; 100 ; mgrubus idaeusPlant
Guarānas ekstraktsplants ; Guarānas ekstrakts ; Paullinia cupana ; 80 ; mgpaullinia cupanaPlant
Kajēnas piparu ekstraktsplants ; Kajēnas piparu ekstrakts ; Capsicum annuum ; 70 ; mgcapsicum annuumPlant
Zaļo kafijas pupiņu ekstraktsplants ; Zaļo kafijas pupiņu ekstrakts ; Coffea canephora ; 60 ; mgcoffea canephoraPlant
Melno piparu ekstraktsplants ; Melno piparu ekstrakts ; Piper nigrum ; 10 ; mgpiper nigrumPlant
L-karnitīna-L-tartrātsotherIngredients ; L-karnitīna-L-tartrāts ; 272 ; mgNot recognisedRole not identified
KofeīnsotherIngredients ; Kofeīns ; 133.4 ; mgNot recognisedRole not identified
SINETROL® (patentēts citrusaugļu un guarānas ekstrakts - Citrus paradisi Macafad., Citrus sinensis (L.)Osbeck, Paullinia cupana Kunth)otherIngredients ; SINETROL® (patentēts citrusaugļu un guarānas ekstrakts - Citrus paradisi Macafad., Citrus sinensis (L.)Osbeck, Paullinia cupana Kunth) ; 40 ; mgcitrus paradisiPlant
L-teanīnsotherIngredients ; L-teanīns ; 20 ; mgNot recognisedRole not identified
Mikrokristāliskā celuloze (E460)otherIngredients ; Mikrokristāliskā celuloze (E460)Listed as food additive E 460(i) (EU Union list)Role not identified
Polietilēnglikols (E1521)otherIngredients ; Polietilēnglikols (E1521)Listed as food additive E 1521 (EU Union list)Role not identified
Talks (E553b)otherIngredients ; Talks (E553b)Listed as food additive E 553b (EU Union list)Role not identified
Polivinilspirts (E1203)otherIngredients ; Polivinilspirts (E1203)Listed as food additive E 1203 (EU Union list)Role not identified
Kālija alumīnija silikātsotherIngredients ; Kālija alumīnija silikātsListed as food additive E 555 (EU Union list)Role not identified
Polioksietilēna sorbitāna monooleāts (E433)otherIngredients ; Polioksietilēna sorbitāna monooleāts (E433)Listed as food additive E 433 (EU Union list)Role not identified
Šķēršūtā nātrija karboksimetilceluloze (E468)otherIngredients ; Šķēršūtā nātrija karboksimetilceluloze (E468)Listed as food additive E 468 (EU Union list)Role not identified
Taukskābju magnija sāļi (E470b)otherIngredients ; Taukskābju magnija sāļi (E470b)Listed as food additive E 470b (EU Union list)Role not identified
Silīcija dioksīds (E551)otherIngredients ; Silīcija dioksīds (E551)Listed as food additive E 551 (EU Union list)Role not identified
Titāna dioksīds (E171)otherIngredients ; Titāna dioksīds (E171)Not recognisedRole not identified

Quantities are reproduced as published. The export does not specify their basis: the recommended daily intake cannot be used to calculate a daily dose. No daily dose is estimated. Latvian names are retained without translation.

Manufacturer countries

Polija

French and European references for recognised ingredients

Unrecognised ingredients are not assessed. The absence of a signal does not establish product compliance.

Official source

View the official register

Official PVD export

Internet Archive copy dated 3 May 2025

PVD, food supplement register, CC0 1.0. Quantities and the date of each snapshot are retained as published.

CC0 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Nātru ekstrakts
    Read the warning, when it applies and the studies cited

    STINGING NETTLE JUICE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products except nutritive tonics.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Do not use if you are pregnant or breastfeeding (Brinker 2010; Barnes et al. 2007; Tilgner 1999).

    Sources cited by Health Canada (3)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Tilgner S. Herbal Medicine from the Heart of the Earth. Creswell (OR): Wise Acre Press; 1999.

    Known adverse reactions

    Condition of application: All products except those making only a diuretic claim*.

    When using this product diuretic effect may occur.

    *Note: This statement can be removed from the label if a diuretic claim is included.

    Health Canada monograph dated 27 March 2026

    STINGING NETTLE - URTICA DIOICA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products except nutritive tonics.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Do not use if you are pregnant or breastfeeding (Brinker 2010; Barnes et al. 2007; Tilgner 1999).

    Sources cited by Health Canada (3)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Tilgner S. Herbal Medicine from the Heart of the Earth. Creswell (OR): Wise Acre Press; 1999.

    Known adverse reactions

    All products except those making only a diuretic claim*

    When using this product diuretic effect may occur.

    *Note: This statement can be removed from the label if a diuretic claim is included.

    Health Canada monograph dated 27 March 2026

  • Kajēnas piparu ekstrakts
    Read the warning, when it applies and the studies cited

    CAYENNE - CAPSICUM ANNUUM Oral

    Cautions and warnings

    Condition of application: All products.

    Keep out of the reach of children. If overdose or accidental ingestion occurs, call a poison control centre or get medical help right away (CPS 2008).

    Sources cited by Health Canada (1)
    • CPS 2008: Repchinksy C, Welbanks L, Bhalla A, Fortin K, Jarvis B, Jovaisas B, Acharya S. Compendium of Pharmaceutical Specialties. Ottawa (ON): Canadian Pharmacists Association; 2008.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Bradley 2006; Boon and Smith 2004).

    Sources cited by Health Canada (2)
    • Boon H, Smith MJ. The Complete Natural Medicine Guide to the 50 Most Common Medicinal Herbs, 2nd edition. Toronto (ON): Robert Rose Inc; 2004.
    • Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (GB): British Herbal Medicine Association; 2006.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have stomach ulcers or inflammation (Brinker 2010).

    Sources cited by Health Canada (1)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Condition of application: Digestion; Peripheral circulation.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 27 March 2026

    CAYENNE - CAPSICUM ANNUUM/CAPSAICIN Topical

    Cautions and warnings

    Condition of application: All products.

    For external use only (US FDA 2023).

    Sources cited by Health Canada (1)
    • US FDA 2023: United States Food and Drug Administration. Over-the-Counter Monograph M017: External Analgesics Drug Products for Over-the-Counter Human Use. Washington (DC): U.S. Food and Drug Administration, Department of Health and Human Services. [Accessed 2026 February 27]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/omuf/monographs/OTC%20Monograph_M017-External%20Analgesic%20Drug%20Products%20for%20OTC%20Human%20Use%2005.02.2023.pdf

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    When using this product avoid contact with the eyes and mucous membranes. If contact occurs, rinse thoroughly with water (US FDA 2023).

    Sources cited by Health Canada (1)
    • US FDA 2023: United States Food and Drug Administration. Over-the-Counter Monograph M017: External Analgesics Drug Products for Over-the-Counter Human Use. Washington (DC): U.S. Food and Drug Administration, Department of Health and Human Services. [Accessed 2026 February 27]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/omuf/monographs/OTC%20Monograph_M017-External%20Analgesic%20Drug%20Products%20for%20OTC%20Human%20Use%2005.02.2023.pdf

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist, worsen, or re-occur within a few days (US FDA 2023).

    Sources cited by Health Canada (1)
    • US FDA 2023: United States Food and Drug Administration. Over-the-Counter Monograph M017: External Analgesics Drug Products for Over-the-Counter Human Use. Washington (DC): U.S. Food and Drug Administration, Department of Health and Human Services. [Accessed 2026 February 27]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/omuf/monographs/OTC%20Monograph_M017-External%20Analgesic%20Drug%20Products%20for%20OTC%20Human%20Use%2005.02.2023.pdf

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Keep out of the reach of children. If swallowed, call a poison control centre or get medical help right away (CPS 2008).

    Sources cited by Health Canada (1)
    • CPS 2008: Repchinksy C, Welbanks L, Bhalla A, Fortin K, Jarvis B, Jovaisas B, Acharya S. Compendium of Pharmaceutical Specialties. Ottawa (ON): Canadian Pharmacists Association; 2008.

    Known adverse reactions

    Condition of application: All products.

    Stop use if headache, redness, rashes, burning discomfort and/or hypersensitivity occur (Brayfield and Cadart 2024; Zhang et al. 2008; Hoffman 2003; APhA 2002; McCleane 2000).

    Sources cited by Health Canada (5)
    • APhA 2002: Berardi RR, DeSimone EM, Newton GGD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze KJ, editors. Handbook of Nonprescription Drugs: An interactive approach to self-care. 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
    • Brayfield A, Cadart C, editors. Martindale: The Complete Drug Reference. London (GB): Pharmaceutical Press; 2024. [Accessed 2024 August 14]. Available from: https://www.medicinescomplete.com/#/browse/martindale
    • Hoffman D. Medical Herbalism: The Science and Practice of Herbal Medicine. Rochester (VT): Healing Arts Press; 2003.
    • McCleane G. Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study. British Journal of Clinical Pharmacology 2000;49:574-579. PubMed Randomised trial
    • Zhang W, Moskowitz, RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis and Cartilage 2008;16:137-162. PubMed Systematic review

    Health Canada monograph dated 27 March 2026

  • Zaļo kafijas pupiņu ekstrakts
    Read the warning, when it applies and the studies cited

    GREEN COFFEE BEAN EXTRACT

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.

    Contraindications

    Do not use if you are pregnant.

    Health Canada monograph dated 31 October 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “QUEEN FIT™ Define It Lady™ (Paziņots 2015.)”, https://compoatlas.com/en/supplements/latvia/5201-queen-fittm-define-it-ladytm-pazinots-2015, updated 28 October 2026.

Enter to analyse, Shift+Enter for a new line